Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Saborowski

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|October 26, 2023
IMbrave050: the first step towards adjuvant therapy in hepatocellular carcinomaArndt Vogel, Tim Meyer, Anna Saborowski
Expert Opinion on Investigational Drugs|December 31, 2020
Immunotherapies in clinical development for biliary tract cancerArndt Vogel, Melanie Bathon, Anna Saborowski
Expert Review of Anticancer Therapy|January 27, 2021
Advances in systemic therapy for the first-line treatment of unresectable HCCArndt Vogel, Melanie Bathon, Anna Saborowski
Trends in Cancer|November 29, 2021
Combination therapies for targeting FGFR2 fusions in cholangiocarcinomaAnna Saborowski, Arndt Vogel, Oreste Segatto
Innere Medizin (Heidelberg, Germany)|February 12, 2025
[Liver transplantation in patients with unresectable colorectal liver metastases]Markus Quante, Anna Saborowski, Sirka Nitschmann
Therapeutic Advances in Medical Oncology|September 28, 2020
FGFR inhibitors in cholangiocarcinoma: what's now and what's next?Anna Saborowski, Ulrich Lehmann, Arndt Vogel
Expert Opinion on Pharmacotherapy|November 19, 2024
Systemic approaches in biliary tract cancers: a review in the era of multidirectional precision medicineCha Len Lee, Anna Saborowski, Arndt Vogel
Annual Review of Medicine|September 28, 2022
FGFR2 Inhibition in CholangiocarcinomaArndt Vogel, Oreste Segatto, Albrecht Stenzinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Finding the Right Partner: Triplet Therapy for First-Line Advanced Biliary Tract CancersXin Wang, Anna Saborowski, Gonzalo Sapisochin, et al.
Targeted Oncology|February 27, 2019
The Changing Landscape of Systemic Treatment of Advanced Hepatocellular Carcinoma: New Targeted Agents and ImmunotherapiesJens U Marquardt, Anna Saborowski, Carolin Czauderna, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|October 26, 2023
IMbrave050: the first step towards adjuvant therapy in hepatocellular carcinomaArndt Vogel, Tim Meyer, Anna Saborowski
Expert Opinion on Investigational Drugs|December 31, 2020
Immunotherapies in clinical development for biliary tract cancerArndt Vogel, Melanie Bathon, Anna Saborowski
Expert Review of Anticancer Therapy|January 27, 2021
Advances in systemic therapy for the first-line treatment of unresectable HCCArndt Vogel, Melanie Bathon, Anna Saborowski
Trends in Cancer|November 29, 2021
Combination therapies for targeting FGFR2 fusions in cholangiocarcinomaAnna Saborowski, Arndt Vogel, Oreste Segatto
Innere Medizin (Heidelberg, Germany)|February 12, 2025
[Liver transplantation in patients with unresectable colorectal liver metastases]Markus Quante, Anna Saborowski, Sirka Nitschmann
Therapeutic Advances in Medical Oncology|September 28, 2020
FGFR inhibitors in cholangiocarcinoma: what's now and what's next?Anna Saborowski, Ulrich Lehmann, Arndt Vogel
Expert Opinion on Pharmacotherapy|November 19, 2024
Systemic approaches in biliary tract cancers: a review in the era of multidirectional precision medicineCha Len Lee, Anna Saborowski, Arndt Vogel
Annual Review of Medicine|September 28, 2022
FGFR2 Inhibition in CholangiocarcinomaArndt Vogel, Oreste Segatto, Albrecht Stenzinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Finding the Right Partner: Triplet Therapy for First-Line Advanced Biliary Tract CancersXin Wang, Anna Saborowski, Gonzalo Sapisochin, et al.
Targeted Oncology|February 27, 2019
The Changing Landscape of Systemic Treatment of Advanced Hepatocellular Carcinoma: New Targeted Agents and ImmunotherapiesJens U Marquardt, Anna Saborowski, Carolin Czauderna, et al.
Pageof 8